Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
3.830
+0.010 (0.26%)
At close: Jun 12, 2026, 4:00 PM EDT
3.840
+0.010 (0.26%)
After-hours: Jun 12, 2026, 7:19 PM EDT
Incannex Healthcare Market Cap
Incannex Healthcare has a market cap or net worth of $45.82 million as of June 12, 2026. Its market cap has increased by 122.31% in one year.
Market Cap
45.82M
Enterprise Value
-28.51M
1-Year Change
122.31%
Ranking
Category
Stock Price
$3.83
Market Cap Chart
Since March 2, 2022, Incannex Healthcare's market cap has decreased from $17.98B to $45.82M, a decrease of -99.75%. That is a compound annual growth rate of -75.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 45.82M | -63.03% |
| Dec 31, 2025 | 123.95M | 231.39% |
| Dec 31, 2024 | 37.40M | -49.22% |
| Dec 29, 2023 | 73.65M | -98.35% |
| Dec 30, 2022 | 4.47B | -75.16% |
| Mar 2, 2022 | 17.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 83.91M |
| BGM Group | 68.98M |
| Citius Oncology | 58.61M |
| InterCure | 49.24M |
| Talphera | 45.33M |
| SCYNEXIS | 42.01M |
| Zhengye Biotechnology Holding | 39.34M |
| BioXcel Therapeutics | 35.20M |